New User? Sign Up Free
SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.
Shannon S. Carson, MD, as well as John P. Kress, MD, discuss their article from the May 2006 Critical Care Medicine, "A Randomized Trial of Intermittent Lorazepam vs. Propofol With Daily Interruption in Mechanically Ventilated Patients."
Troy E. Batterton, PharmD, and Dean Sandifer, MD, discuss sedation strategies in critical care, including designing, building and maintaining protocols in intensive care units.
Michael Weinstein, MD, FACS, FCCP, speaks with Christopher W. Seymour, MD, MSc, lead author on an article published in the October Critical Care Medicine, “Diurnal Sedative Changes During Intensive Care: Impact on Liberation from Mechanical Ventilation and Delirium.”
Kyle B. Enfield, MD, speaks with John W. Devlin, PharmD, FCCM, about the article "Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU" (Devlin JW, et al. Crit Care Med. 2018;46:e825-e873).
Ped Crit Care Med. 2022;23:e74-e110.
Shehabi et al (N Engl J Med. 2019;380:2506-2517) set out to examine the effects of using dexmedetomidine as the primary agent for early sedation among patients receiving ventilatory support and found that the dexmedetomidine group had a higher risk of adverse events and needed additional sedatives to achieve sedation goals.
Crit Care Med. 2018 Sep;46(9):e825-e873.
Crit Care Med. 2016;44(11):2079-2103